Table 2.
End-point | GTV-P cut-off value | ||||||||
---|---|---|---|---|---|---|---|---|---|
46.4 mL | 57.9 mL | 75.4 mL | |||||||
Sensitivity (%) | Specificity (%) | AUC | Sensitivity (%) | Specificity (%) | AUC | Sensitivity (%) | Specificity (%) | AUC | |
OS | 59.4 | 66 | 0.662 | 39.1 | 79.4 | – | 26.6 | 90.4 | – |
LRFS | 50 | 62 | – | 62.5 | 77.9 | 0.702 | 25 | 88 | – |
DMFS | 61.8 | 65.6 | – | 40 | 79.2 | – | 36.4 | 91.8 | 0.668 |
DFS | 56.6 | 66.9 | 0.668 | 37.5 | 80.1 | – | 26.5 | 91.6 | – |
Twelve patients were lost to follow-up and, thus, were not included in the survival analysis
AUC area under the curve, OS overall survival, LRFS local relapse-free survival, DMFS distant metastasis-free survival, DFS disease-free survival
– AUC of inferior cut-off value for the endpoint was not calculated